3050-5674

ASPET Discovery

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 30 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact30 DOIs
2

Attach ORCID iDs across 4 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact4 DOIs
3

Deposit reference lists for 1 record

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact1 DOIs

DOIs for this ISSN

Showing the top 5 of 30 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 In vitro and in silico pharmacological profiling of 3-(4,5-d… (10.1016/j.aspetd.2025.100004)
Abstract
30.76 16
2 Quantitative structure-activity relationship-guided design a… (10.1016/j.aspetd.2025.100015)
Abstract
23.86 8
3 Integrative strategies in breast cancer therapy: Conventiona… (10.1016/j.aspetd.2025.100012)
Abstract
22.58 7
4 Pharmacological modulation of the gut microbiota and endotox… (10.1016/j.aspetd.2025.100010)
Abstract
21.13 6
5 NEK2 inhibition alleviates lipopolysaccharide-induced endoth… (10.1016/j.aspetd.2025.100002)
Abstract
15.05 3
6 Evaluation of molecular glue–induced neomorphic protein-prot… (10.1016/j.aspetd.2025.100003)
Abstract
15.05 3
7 Strain-dependent neuronal disposition and toxicity of paclit… (10.1016/j.aspetd.2025.100005)
Abstract
15.05 3
8 Ecofriendly silver nanoparticle synthesis, physicochemical c… (10.1016/j.aspetd.2025.100008)
Abstract
15.05 3
9 Unveiling the therapeutic mechanisms of Shenshu powder in CO… (10.1016/j.aspetd.2025.100013)
Abstract ORCID
15.05 1
10 Advances in computer-aided drug design: From molecular docki… (10.1016/j.aspetd.2026.100024)
Abstract
15.05 3
11 Hibiscus sabdariffa Linn. protects against cerebral ischemia… (10.1016/j.aspetd.2025.100009)
Abstract
11.93 2
12 A new frontier: Terpenes in the fight against colon cancer (10.1016/j.aspetd.2025.100016)
Abstract
11.93 2
13 Levetiracetam: An antiseizure drug with unique neuroprotecti… (10.1016/j.aspetd.2025.100006)
Abstract
7.53 1
14 Targeting ribonucleotide reductase to enhance the antileukem… (10.1016/j.aspetd.2025.100014)
Abstract
7.53 1
15 Differential effects of acute versus repeated chemogenetic a… (10.1016/j.aspetd.2026.100020)
Abstract
7.53 1
16 Insights and perspectives into the etiology of TKI-induced c… (10.1016/j.aspetd.2026.100025)
Abstract
7.53 1
17 ASPET Discovery launches! (10.1016/j.aspetd.2024.100001)
Abstract References ORCID
0.00 0
18 In silico design of 3-methyl-3H-naphtho[1,2,3-de]quinoline-2… (10.1016/j.aspetd.2025.100007)
Abstract
0.00 0
19 Cheating death: How a porphyrin transporter fuels survival i… (10.1016/j.aspetd.2025.100011)
Abstract
0.00 0
20 A systematic review of preclinical studies of medicinal plan… (10.1016/j.aspetd.2025.100017)
Abstract ORCID
0.00 0
21 Flavan-3-gallate catechins in green tea (Camellia sinensis)… (10.1016/j.aspetd.2025.100018)
Abstract
0.00 0
22 Methyl eugenol as a multitarget-directed ligand for Alzheime… (10.1016/j.aspetd.2025.100019)
Abstract
0.00 0
23 Association of glyoxalase I inhibition by angiotensin II rec… (10.1016/j.aspetd.2026.100021)
Abstract
0.00 0
24 Endoxifen-glucuronide and 4-hydroxy-tamoxifen glucuronide ar… (10.1016/j.aspetd.2026.100022)
Abstract
0.00 0
25 Standardized Tribulus terrestris L. extract ameliorates neur… (10.1016/j.aspetd.2026.100023)
Abstract ORCID
0.00 0
26 PP2A regulation in acute myeloid leukemia: Mechanisms, stem… (10.1016/j.aspetd.2026.100026)
Abstract
0.00 0
27 Neo-protein-protein interaction rewires oncogenic BRAF mutat… (10.1016/j.aspetd.2026.100027)
Abstract
0.00 0
28 Behavioral pharmacology in biopharma drug discovery: With gr… (10.1016/j.aspetd.2026.100028)
Abstract
0.00 0
29 Emerging concepts on one-carbon metabolism as a unique and a… (10.1016/j.aspetd.2026.100029)
Abstract
0.00 0
30 A soliloquy on synergy (10.1016/j.aspetd.2026.100030)
Abstract
0.00 0